Summary
Two cases of severe myeloneuropathy and macrocytic anemia associated with a low serum level of vitamin B12 after prolonged exposure to nitrous oxide are reported. In both cases, the neurological manifestations worsened initially despite B12 supplementation, al though in one case the use of methionine seemed to arrest the progression of the disease and accelerate recovery. This offers further support for the biochemical hypothesis of methionine synthetase inhibition by nitrous oxide and reproduces in man previously reported animal studies with methionine. Methionine may be an important first-line therapy in the initial treatment of neuropathy and myeloneuropathy induced by nitrous oxide, and has a hypothetical role in the treatment of subacute combined degeneration of the cord.
This is a preview of subscription content, access via your institution.
References
Amess JAL, Burman JF, Rees GM, Nancekievill DG, Mollin DL (1978) Megaloblastic haemopoiesis in patients receiving nitrous oxide. Lancet II:339–342
Blanco G, Peters HA (1983) Myeloneuropathy and macrocytosis associated with nitrous oxide abuse. Arch Neurol 40:416–418
Deacon R, Lumb M, Perry J, Chanarin I, Minty B, Halsey MJ, Nunn JF (1978) Selective inactivation of vitamin B12 in rats by nitrous oxide. Lancet 11:1023–1024
Fairbanks VF, Elveback LR (1983) Tests for pernicious anemia: serum vitamin Bit assay. Mayo Clin Proc 58:135–137
Gillman MA (1987) Haematological changes caused by nitrous oxide. Br J Anaesth 59:143–146
Heyer EJ, Simpson DM, Bodis-Wollner I, Diamond SP (1986) Nitrous oxide: clinical and electrophysiologic investigation of neurologic complications. Neurology 36:1618–1622
Kolhouse JF, Kondo NC, Allen NC, Podell ER, Allen RH (1978) Cobalamin analogues are present in human plasma and can mask cobalamin deficiency because current radioisotope dilution assays are not specific for true cobalamin. N Engl J Med 299:785–792
Kondo H, et al (1981) Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activity of both mammalian cobalamin-dependent enzymes in rats. J Clin Invest 67:1270–1283
Layzer RB (1978) Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet 11:1227–1230
Layzer RB (1985) Neuromuscular manifestations of systemic disease. Davis, Philadelphia, pp 327–400
Layzer RB, Fishman RA, Schafer JA (1978) Neuropathy following abuse of nitrous oxide. Neurology 28:504–506
Lindenbaum J, et al (1988) Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 318:1720–1728
Lindenbaum J, Savage DG, Stabler SP, Allen RH (1990) Diagnosis of cobalamin deficiency. II. Relative sensitivities of serum cobalamin, methylmalonic acid and total homocysteine concentrations. Am J Hematol 34:99–107
Lombardini JB, Coulter AW, Talay P (1970) Analogues of methionine as substrates and inhibitors of the methionine adenosyltransferase reaction. Deductions concerning the conformation of methionine. Mol Pharmacol 6:481–499
McCann SR, Weir DJ, Dinn JJ, Wilson P, Scott J (1979) Neurological damage induced by nitrous oxide in the monkey in absence of any detectable haematological change. Br J Haematol 43:496
Nunn JF (1987) Clinical aspects of the interaction between nitrous oxide and vitamin B12. Br J Anaesth 59:3–13
Pulsson GW (1979) “Recreational” misuse of nitrous oxide. J Am Dent Assoc 98:410–411
Sahenk Z, Mendell JR, Couri D, Nachtman J (1978) Polyneuropathy from inhalation of N20 cartridges through a whippedcream dispenser. Neurology 28:485–487
Schilling RF (1986) Is nitrous oxide a dangerous anesthetic for vitamin B12-deficient subjects? JAMA 255:1605–1606
Scott JM, Weir DJ (1981) The methyl folate trap. Lancet II:337–340
Scott JM, Dinn JJ, Wilson P, Weir DG (1981) Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet II:334–337
Shimizu T, Nishimura Y, Fujishima Y, Miyajima H, Honda N (1989) Subacute myeloneuropathy after abuse of nitrous oxide: an electron microscopic study on the peripheral nerve (in Japanese). Rinsho Shinkergaku 29:129–135
Vina JR, Davis DW, Hawkins RA (1986) The influence of nitrous oxide on methionine, S-adenosylmethionine, and other amino acids. Anesthesiology 64:490–495
Williams SR (1989) Nutrition and diet therapy, 6th edn. Times Mirror, Mosby, St Louis Toronto Boston, pp 874–875
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stacy, C.B., Di Rocco, A. & Gould, R.J. Methionine in the treatment of nitrous-oxide-induced neuropathy and myeloneuropathy. J Neurol 239, 401–403 (1992). https://doi.org/10.1007/BF00812159
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00812159